Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$5.03
+2.0%
$5.76
$1.38
$7.61
$83.70M1.2119,845 shs26,281 shs
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
$0.31
$0.36
$0.17
$0.50
$86.38M0.813,479 shsN/A
PAVmed Inc. stock logo
PAVM
PAVmed
$1.85
-1.1%
$2.19
$1.60
$9.00
$17.15M0.8565,342 shs18,506 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.50
-1.3%
$17.65
$14.51
$22.99
$65.84M0.67,942 shs4,522 shs
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$0.02
$0.02
$0.00
$0.03
$25.09M0.99333,942 shs90,160 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BrainsWay Ltd. stock logo
BWAY
BrainsWay
+1.93%-0.40%-7.37%-17.68%+224.52%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
0.00%-3.64%-8.26%-17.84%+40.91%
PAVmed Inc. stock logo
PAVM
PAVmed
-1.07%-6.09%-16.29%-25.10%-74.34%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-1.33%+1.31%+7.37%-14.15%+15.99%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
+4.55%-4.56%+9.52%0.00%-9.80%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.6936 of 5 stars
3.35.00.00.02.80.80.6
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/AN/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
1.787 of 5 stars
3.00.00.04.33.20.80.0
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.67
Moderate Buy$7.0039.17% Upside
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
2.00
Hold$21.001,035.14% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/A

Current Analyst Ratings

Latest PAVM, PDEX, BWAY, EDTXF, and SNWV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/11/2024
BrainsWay Ltd. stock logo
BWAY
BrainsWay
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$31.78M2.63N/AN/A$2.50 per share2.01
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
$1.18M73.20N/AN/A($0.04) per share-7.75
PAVmed Inc. stock logo
PAVM
PAVmed
$2.45M6.92N/AN/A($3.35) per share-0.55
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$48.24M1.35$2.23 per share8.28$8.91 per share2.08
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$20.40M1.29N/AN/A($0.04) per share-0.58

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$4.20M-$0.13N/A62.88N/A-13.20%-10.05%-6.88%5/15/2024 (Estimated)
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
-$11.60M-$0.04N/AN/A-974.16%N/A-210.60%5/10/2024 (Estimated)
PAVmed Inc. stock logo
PAVM
PAVmed
-$64.18M-$9.33N/AN/A-2,617.25%N/A-85.99%5/21/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7524.67N/A5.59%8.97%5.40%5/2/2024 (Estimated)
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
-$25.81M-$0.03N/AN/A-126.52%N/A-32.63%5/10/2024 (Estimated)

Latest PAVM, PDEX, BWAY, EDTXF, and SNWV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A-$0.02-$0.02-$0.02N/A$0.27 million
3/26/2024Q4 2023
PAVmed Inc. stock logo
PAVM
PAVmed
N/A-$1.57-$1.57-$1.16N/A$1.05 million
3/21/2024Q4 2023
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A$0.03+$0.03$0.03N/A$6.99 million
3/6/202412/31/2023
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$0.03-$0.01+$0.02N/A$8.40 million$9.03 million    
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/AN/AN/AN/AN/A
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/A
5.68
5.30
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A
0.40
0.37
PAVmed Inc. stock logo
PAVM
PAVmed
N/A
0.45
0.45
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A
0.15
0.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BrainsWay Ltd. stock logo
BWAY
BrainsWay
30.11%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A
PAVmed Inc. stock logo
PAVM
PAVmed
19.93%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
42.53%

Insider Ownership

CompanyInsider Ownership
BrainsWay Ltd. stock logo
BWAY
BrainsWay
19.00%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
1.50%
PAVmed Inc. stock logo
PAVM
PAVmed
12.60%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
16.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BrainsWay Ltd. stock logo
BWAY
BrainsWay
13416.64 million13.48 millionNot Optionable
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
29278.64 million274.46 millionNot Optionable
PAVmed Inc. stock logo
PAVM
PAVmed
1079.17 million8.02 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
311.14 billion953.51 millionNot Optionable

PAVM, PDEX, BWAY, EDTXF, and SNWV Headlines

SourceHeadline
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
globenewswire.com - April 10 at 8:30 AM
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial OfficerSANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
globenewswire.com - April 1 at 4:00 PM
SANUWAVE Health, Inc. (PNK:SNWV) Q4 2023 Earnings Call TranscriptSANUWAVE Health, Inc. (PNK:SNWV) Q4 2023 Earnings Call Transcript
msn.com - March 25 at 7:14 PM
SANUWAVE Announces Record Q4 and FY2023 RevenueSANUWAVE Announces Record Q4 and FY2023 Revenue
globenewswire.com - March 22 at 6:00 AM
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial ResultsSANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
globenewswire.com - March 20 at 7:00 AM
SANUWAVE Health, Inc.: SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of StockholdersSANUWAVE Health, Inc.: SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
finanznachrichten.de - February 23 at 10:24 AM
SANUWAVE Health Stock (OTC:SNWV) Dividends: History, Yield and DatesSANUWAVE Health Stock (OTC:SNWV) Dividends: History, Yield and Dates
benzinga.com - February 23 at 10:24 AM
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of StockholdersSANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
globenewswire.com - February 22 at 5:00 PM
SEP Acquisition shareholders approve Sanuwave SPAC mergerSEP Acquisition shareholders approve Sanuwave SPAC merger
msn.com - February 1 at 7:46 PM
Sanuwave Health Announces New Financial Obligation RegistrationSanuwave Health Announces New Financial Obligation Registration
msn.com - January 26 at 10:25 PM
EQS-News: SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)EQS-News: SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
markets.businessinsider.com - January 22 at 8:28 AM
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
finance.yahoo.com - January 22 at 8:28 AM
Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/YSanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y
msn.com - January 10 at 12:43 PM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
finance.yahoo.com - January 10 at 7:42 AM
SANUWAVE Health, Inc.: SANUWAVE Announces Q3 2023 Financial ResultsSANUWAVE Health, Inc.: SANUWAVE Announces Q3 2023 Financial Results
finanznachrichten.de - November 11 at 1:34 AM
SANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlookSANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlook
msn.com - November 10 at 10:33 AM
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial ResultsSANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
finance.yahoo.com - November 8 at 8:20 PM
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
finance.yahoo.com - October 10 at 9:30 AM
Sanuwave to go public in $127.5M SPAC mergerSanuwave to go public in $127.5M SPAC merger
massdevice.com - August 24 at 5:32 PM
Sanuwave Health eyes Nasdaq listing, announces merger with SEP AcquisitionSanuwave Health eyes Nasdaq listing, announces merger with SEP Acquisition
msn.com - August 23 at 5:25 PM
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed CompanySANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
finance.yahoo.com - August 23 at 5:25 PM
SANUWAVE Health, Inc.: SANUWAVE Announces Q2 2023 Financial ResultsSANUWAVE Health, Inc.: SANUWAVE Announces Q2 2023 Financial Results
finanznachrichten.de - August 11 at 8:09 AM
SANUWAVE Announces Q2 2023 Financial ResultsSANUWAVE Announces Q2 2023 Financial Results
finance.yahoo.com - August 11 at 8:09 AM
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial ResultsSANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
finance.yahoo.com - August 9 at 8:35 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BrainsWay logo

BrainsWay

NASDAQ:BWAY
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Spectral Medical logo

Spectral Medical

OTCMKTS:EDTXF
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
PAVmed logo

PAVmed

NASDAQ:PAVM
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
SANUWAVE Health logo

SANUWAVE Health

OTCMKTS:SNWV
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide therapeutic treatment of musculoskeletal conditions. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.